Coimbra Genomics

Genetically informed medicine

Big Idea

Genetics is still lagging behind within clinical practice, thus hindering the fulfillment of its full potential. This is mainly due to communication and understanding barriers between Genetic Labs, Health Units and Physicians, that consequently generate an enormous gap and hinder the usage of genetic tests within clinical practice. Coimbra Genomics aims to fill that gap, as it believes in Genetic Intelligence as an important clinical decision supporting tool. To this end, it has developed Elsie – a platform and marketplace for genetic tests, which simplifies the whole user experience and management of genetic tests within clinical practice. By closing the gap, Elsie will foster the endogenization of genetics in daily clinical practice, with incredible economic, clinical and social benefits.


Ana Catarina Gomes – CEO.

Portugal Ventures Investment Manager

Miguel Botto